GLIZID XR 30

Glizid XR 30 Tablet is indicated for the management of type 2 diabetes mellitus in adult patients. This medication is classified under the sulfonylureas category, which functions to enhance insulin secretion from the pancreas, thereby aiding in the regulation of blood glucose levels. Effective control of blood sugar is crucial in minimizing the risks of serious diabetes-related complications. The administration of Glizid XR 30 may take place as a monotherapy or in conjunction with other antidiabetic medications, depending on the individual’s health needs. It is advised to take this medication with food to enhance its efficacy and to maintain a consistent dosing schedule daily for optimal results. Your healthcare provider will determine the appropriate dosage, which may be adjusted over time based on your body’s response to treatment. It is important to continue your medication as directed, even if your blood glucose appears to be stable or if you feel well, as discontinuation without medical advice could lead to an increase in blood sugar levels, posing dangers such as kidney damage, loss of vision, and neuropathy. This medication is a component of a broader diabetes management strategy that also includes dietary modifications, physical activity, and weight control, as per your medical guidance. Awareness of symptoms associated with low blood glucose, such as sweating, dizziness, headaches, and trembling, is essential, as is having quick-access sources of glucose like candy or juice available. While taking this medication, weight gain may occur in some patients, and it is contraindicated in those with type 1 diabetes, diabetic ketoacidosis, or significant renal or hepatic impairment. Prior to initiation, it is imperative to disclose any history of cardiovascular, thyroid, or hormonal disorders to your healthcare provider, who may also recommend routine monitoring of blood glucose levels and conduct tests to evaluate blood cell counts and liver function as part of your care.